Overexpression of miR-216a/217 acts as a positive feedback regulator for the PI3K/AKT and TGF-β pathways by targeting PTEN and SMAD7, resulting in hepatocarcinogenesis and HCC recurrence. Here, TGFB1 is linked to hepatocellular carcinoma.